COVID-19-associated headache

Revision as of 05:07, 21 July 2020 by MoisesRomo (talk | contribs)
Jump to navigation Jump to search

WikiDoc Resources for COVID-19-associated headache

Articles

Most recent articles on COVID-19-associated headache

Most cited articles on COVID-19-associated headache

Review articles on COVID-19-associated headache

Articles on COVID-19-associated headache in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on COVID-19-associated headache

Images of COVID-19-associated headache

Photos of COVID-19-associated headache

Podcasts & MP3s on COVID-19-associated headache

Videos on COVID-19-associated headache

Evidence Based Medicine

Cochrane Collaboration on COVID-19-associated headache

Bandolier on COVID-19-associated headache

TRIP on COVID-19-associated headache

Clinical Trials

Ongoing Trials on COVID-19-associated headache at Clinical Trials.gov

Trial results on COVID-19-associated headache

Clinical Trials on COVID-19-associated headache at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on COVID-19-associated headache

NICE Guidance on COVID-19-associated headache

NHS PRODIGY Guidance

FDA on COVID-19-associated headache

CDC on COVID-19-associated headache

Books

Books on COVID-19-associated headache

News

COVID-19-associated headache in the news

Be alerted to news on COVID-19-associated headache

News trends on COVID-19-associated headache

Commentary

Blogs on COVID-19-associated headache

Definitions

Definitions of COVID-19-associated headache

Patient Resources / Community

Patient resources on COVID-19-associated headache

Discussion groups on COVID-19-associated headache

Patient Handouts on COVID-19-associated headache

Directions to Hospitals Treating COVID-19-associated headache

Risk calculators and risk factors for COVID-19-associated headache

Healthcare Provider Resources

Symptoms of COVID-19-associated headache

Causes & Risk Factors for COVID-19-associated headache

Diagnostic studies for COVID-19-associated headache

Treatment of COVID-19-associated headache

Continuing Medical Education (CME)

CME Programs on COVID-19-associated headache

International

COVID-19-associated headache en Espanol

COVID-19-associated headache en Francais

Business

COVID-19-associated headache in the Marketplace

Patents on COVID-19-associated headache

Experimental / Informatics

List of terms related to COVID-19-associated headache

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D. Syed Musadiq Ali M.B.B.S.[2]

Synonyms and keywords:

Overview

The association between COVID-19 and headache was made in 2020. COVID-19 associated headache may be caused by SARS-CoV-2 virus. There is no established system for the classification of COVID-19 associated headache. The exact pathogenesis of headache in COVID 19 patients is not fully understood. It is thought that headache is the result of cytokine release, direct invasion, metabolic disturbances, inflammation, dehydration, and hypoxia. COVID-19-associated headache must be differentiated from other diseases that cause headache, such as migraine, tension-type headache, cluster headache, seizure, meningitis, encephalitis, neurosyphilis, SAH, subdural hematoma, brain tumor, hypertensive encephalopathy, brain abscess, multiple sclerosis, hemorrhagic stroke, Wernickes encephalopathy, and drug toxicity. A positive history of fever and cough in addition to headache is suggestive of COVID-19-associated headache.

Historical Perspective

  • The association between COVID-19 and headache was made in December, 2019 during SARS-CoV-2 outbreak initiated in Wuhan, Hubei Province, China.[1]

Classification

  • There is no established system for the classification of COVID-19 associated headache.

Pathophysiology

By Fahimeh Shojaei, M.D. / https://en.wikipedia.org/wiki/File:Migraine.jpg

Causes

Differentiating COVID-19-associated headache from other Diseases

  • For further information about the differential diagnosis, click here.
  • To view the differential diagnosis of COVID-19, click here.

Epidemiology and Demographics

Incidence / Prevalence

  • WHO reported that more than 462,801 people have been infected worldwide, more than 380,723 of which are outside of China.[6]
  • The incidence/prevalence of COVID-19-associated headache is still unknown.
  • Guan et al. recently reported 13 percent of COVID-19-associated headache among 1099 laboratory-confirmed cases.

Age

  • There is insufficient information regarding age-specific prevalence or incidence of COVID-19-associated headache.

Gender

  • There is insufficient information regarding gender-specific prevalence or incidence of COVID-19-associated headache.

Race

  • There is insufficient information regarding race-specific prevalence or incidence of COVID-19-associated headache.

Risk Factors

  • There are no established risk factors for COVID-19-associated headache.

Screening

  • There is insufficient evidence to recommend routine screening for COVID-19 associated headache.

Natural History, Complications, and Prognosis

Natural History

Complication

Diagnosis

Diagnostic Study of Choice

  • There are no established criteria for the diagnosis of COVID-19-associated headache.

History and Symptoms

  • The hallmark of COVID-19-associated headache is headache.
  • A positive history of fever and cough in addition to headache is suggestive of COVID-19-associated headache.

Common Symptoms

Less Common Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

  • There are no x-ray findings associated with COVID-19-associated headache.

Echocardiography or Ultrasound

CT scan

  • There are no CT scan findings associated with COVID-19-associated headache.

MRI

  • There are no MRI findings associated with COVID-19-associated headache.

Other Imaging Findings

  • There are no other imaging findings associated with COVID-19-associated headache.

Other Diagnostic Studies

  • There are no other diagnostic studies associated with COVID-19-associated headache.

Treatment

Medical Therapy

  • Medical therapy for COVID-assocaited-headache is still controversial[7].
  • The use of NSAIDs, who received treatment early in the disease causes worsening of COVID-19 symptoms according to some anecdotal evidences.
  • In March 11, 2020, Fang et al. reported the hypothesis that ibuprofen (40 mg/kg/dose)[8] can increase the risk of developing severe and fatal COVID-19 since ibuprofen is known to upregulate ACE2 receptors[9].
  • In March 23, 2020, US FDA announced that it is not aware of any evidence that NSAIDs such as ibuprofen could worsen COVID-19[10].
  • The European Medicines Agency and World Health Organization (WHO) have not yet recommended that NSAIDs be avoided.
  • Despite this recommendation, as a precautionary measure many providers are avoiding NSAIDs in patients with COVID-19.
  • In practice, the decision to continue or stop NSAIDs in patients with COVID-19 is made in collaboration between the treating physician and the patient, after a brief discussion on the limited available evidence.
  • More data are needed before broad recommendations are made.

Surgery

  • Surgical intervention is not recommended for the management of COVID-19-associated headache.

Primary Prevention

  • There are no established measures for the primary prevention of COVID-19 associated headache.

Secondary Prevention

References

  1. Meng X, Deng Y, Dai Z, Meng Z (June 2020). "COVID-19 and anosmia: A review based on up-to-date knowledge". Am J Otolaryngol. 41 (5): 102581. doi:10.1016/j.amjoto.2020.102581. PMC 7265845 Check |pmc= value (help). PMID 32563019 Check |pmid= value (help).
  2. Baig, Abdul Mannan; Khaleeq, Areeba; Ali, Usman; Syeda, Hira (2020). "Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms". ACS Chemical Neuroscience. 11 (7): 995–998. doi:10.1021/acschemneuro.0c00122. ISSN 1948-7193.
  3. St-Jean JR, Jacomy H, Desforges M, Vabret A, Freymuth F, Talbot PJ (August 2004). "Human respiratory coronavirus OC43: genetic stability and neuroinvasion". J. Virol. 78 (16): 8824–34. doi:10.1128/JVI.78.16.8824-8834.2004. PMC 479063. PMID 15280490.
  4. Rossi, Andrea (2008). "Imaging of Acute Disseminated Encephalomyelitis". Neuroimaging Clinics of North America. 18 (1): 149–161. doi:10.1016/j.nic.2007.12.007. ISSN 1052-5149.
  5. St-Jean, Julien R.; Jacomy, Hélène; Desforges, Marc; Vabret, Astrid; Freymuth, François; Talbot, Pierre J. (2004). "Human Respiratory Coronavirus OC43: Genetic Stability and Neuroinvasion". Journal of Virology. 78 (16): 8824–8834. doi:10.1128/JVI.78.16.8824-8834.2004. ISSN 0022-538X.
  6. Tu H, Tu S, Gao S, Shao A, Sheng J (2020). "Current epidemiological and clinical features of COVID-19; a global perspective from China". J Infect. 81 (1): 1–9. doi:10.1016/j.jinf.2020.04.011. PMC 7166041 Check |pmc= value (help). PMID 32315723 Check |pmid= value (help).
  7. Zhang J, Xie B, Hashimoto K (2020). "Current status of potential therapeutic candidates for the COVID-19 crisis". Brain Behav Immun. 87: 59–73. doi:10.1016/j.bbi.2020.04.046. PMC 7175848 Check |pmc= value (help). PMID 32334062 Check |pmid= value (help).
  8. MaassenVanDenBrink A, de Vries T, Danser A (April 2020). "Headache medication and the COVID-19 pandemic". J Headache Pain. 21 (1): 38. doi:10.1186/s10194-020-01106-5. PMC 7183387 Check |pmc= value (help). PMID 32334535 Check |pmid= value (help). Vancouver style error: initials (help)
  9. Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8 (4):e21. DOI:10.1016/S2213-2600(20)30116-8 PMID: 32171062
  10. FitzGerald GA (2020) Misguided drug advice for COVID-19. Science 367 (6485):1434. DOI:10.1126/science.abb8034 PMID: 32198292


Template:WikiDoc Sources